Cargando…
Anticancer drug mithramycin interacts with core histones: An additional mode of action of the DNA groove binder
Mithramycin (MTR) is a clinically approved DNA-binding antitumor antibiotic currently in Phase 2 clinical trials at National Institutes of Health for treatment of osteosarcoma. In view of the resurgence in the studies of this generic antibiotic as a human medicine, we have examined the binding prope...
Autores principales: | Banerjee, Amrita, Sanyal, Sulagna, Kulkarni, Kirti K., Jana, Kuladip, Roy, Siddhartha, Das, Chandrima, Dasgupta, Dipak |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4247356/ https://www.ncbi.nlm.nih.gov/pubmed/25473595 http://dx.doi.org/10.1016/j.fob.2014.10.007 |
Ejemplares similares
-
Mithramycin interacts with core histones and modulates epigenetic modifications
por: Banerjee, Amrita, et al.
Publicado: (2013) -
The DNA intercalators ethidium bromide and propidium iodide also bind to core histones
por: Banerjee, Amrita, et al.
Publicado: (2014) -
Global gene expression profiling data analysis reveals key gene families and biological processes inhibited by Mithramycin in sarcoma cell lines
por: Kulkarni, Kirti K., et al.
Publicado: (2014) -
Minor Groove Binder Distamycin Remodels Chromatin but Inhibits Transcription
por: Majumder, Parijat, et al.
Publicado: (2013) -
Effect of DNA Groove Binder Distamycin A upon Chromatin Structure
por: Majumder, Parijat, et al.
Publicado: (2011)